DiaMedica Therapeutics Inc
NASDAQ:DMAC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
DiaMedica Therapeutics Inc
NASDAQ:DMAC
|
US |
Intrinsic Value
The intrinsic value of one
DMAC
stock under the Base Case scenario is
0.35
USD.
Compared to the current market price of 6.79 USD,
DiaMedica Therapeutics Inc
is
Overvalued by 95%.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for DiaMedica Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
DiaMedica Therapeutics Inc
Earnings Waterfall
DiaMedica Therapeutics Inc
The intrinsic value of one
DMAC
stock under the Base Case scenario is
0.35
USD.
Compared to the current market price of 6.79 USD,
DiaMedica Therapeutics Inc
is
Overvalued by 95%.